Kookjeon Pharmaceutical Co., Ltd. (KOSDAQ: A307750)
Health Care · Pharmaceuticals · KR
₩2,095.00
-9.31% today · -47.4% 1Y
Kookjeon Pharmaceutical Co., Ltd. (KOSDAQ: A307750) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $81.61M.
Over the last twelve months the share price has lost 47.4%, trading between 1.70K and 6.00K.
Tweenvest scores Kookjeon Pharmaceutical Co., Ltd. across four factors: quality 53/100, value 65/100, dividend 6/100. Its strongest factor is value.
A307750 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $81.61M
- Revenue (TTM)
- $86.90M
- P/E
- —
- EPS
- -36.19
- Dividend yield
- 0.48%
- Beta (5Y)
- -0.28
- 52-week high
- ₩6,000.00
- 52-week low
- ₩1,700.00
- Avg volume (3M)
- —
- Shares outstanding
- 53.99M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,190.85 | -3.47% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $271.06 | -0.76% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.94 | -1.60% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.70 | -1.10% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.92 | -1.47% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.25 | -1.14% |
Figures last refreshed Aug 18, 2026.